The Role of Aldosteronism in Causing Obesity-Related Cardiovascular Risk

David A. Calhoun, Kumar Sharma

Resultado de la investigación: Review articlerevisión exhaustiva

53 Citas (Scopus)

Resumen

A large body of evidence strongly links aldosterone to development and progression of cardiovascular disease, including vascular stiffness, left ventricular hypertrophy, congestive heart failure, chronic kidney disease, and, especially, hypertension. Emerging data suggest that adipocytes may serve as a source of aldosterone, either directly or indirectly, through the release of aldosterone-stimulating factors. If adipocytes are confirmed to have an important contribution to hyperaldosteronism, it would have significant clinical implications in linking aldosterone to obesity-related increases in cardiovascular risk. Such a cause-and-effect situation would then provide the opportunity to reverse that risk with preferential use of aldosterone antagonists in obese patients.

Idioma originalEnglish (US)
Páginas (desde-hasta)517-527
Número de páginas11
PublicaciónCardiology Clinics
Volumen28
N.º3
DOI
EstadoPublished - ago. 2010
Publicado de forma externa

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Huella

Profundice en los temas de investigación de 'The Role of Aldosteronism in Causing Obesity-Related Cardiovascular Risk'. En conjunto forman una huella única.

Citar esto